Dilution from Stock Options
First written in FY2018. 17 of 18 entries say "Materialised", first in FY2019-Q3. Latest entry: FY2026.
Logizard moved to the "Worse" side of this theme in 2019, 1 year before the typical company in this theme (2020).
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
69 other companies' latest entry also says "Materialised".
- FY2026MaterialisedAnnual report
「1 July 2025–30 June 2026 5,500 3,301,000 660 304,604 660 297,106 (Note) The increase resulted from the exercise of stock acquisition rights by 2 rightsholders.」
In FY2026, the exercise of stock acquisition rights increased the number of shares by 5,500, while stated capital and the capital reserve each increased by ¥660 thousand. The exercise of rights for a further 1,000 shares from July to August 2026 is also disclosed. - FY2026-H1MaterialisedAnnual report
「1 July 2025–31 December 2025 (Note) 2,500 3,298,000 300 304,244 300 296,746 (Note) The increase resulted from the exercise of stock acquisition rights.」
During the interim accounting period, the exercise of stock acquisition rights increased the number of shares by 2,500, and increased both stated capital and capital surplus by ¥300,000 each. - FY2025MaterialisedAnnual report
「1 July 2024–30 June 2025 4,500 3,295,500 540 303,944 540 296,446 (Note) The increase resulted from the exercise of stock acquisition rights by 4 people.」
In FY2025, the exercise of stock acquisition rights increased the number of shares by 4,500, and increased both stated capital and capital surplus by ¥540,000 each. - FY2025-H1MaterialisedAnnual report
「1 July 2024–31 December 2024 4,000 3,295,000 480 303,884 480 296,386 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the interim accounting period, the exercise of stock acquisition rights increased the number of shares by 4,000, and increased both stated capital and capital surplus by ¥480,000 each. Dilution from stock options has continued to materialize. - FY2024-Q2MaterialisedAnnual report
「1 October 2023–31 December 2023 12,000 3,291,000 1,440 303,404 1,440 295,906 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the second quarter accounting period, the exercise of stock acquisition rights resulted in an increase of 12,000 shares and increased share capital and the capital surplus by ¥1.440 million each. - FY2023MaterialisedAnnual report
「1 July 2022–30 June 2023 6,500 3,279,000 780 301,964 780 294,466 (Note) Increase resulting from the exercise of stock acquisition rights by 5 exercising holders.」
During the fiscal year, 6,500 shares were issued through the exercise of stock acquisition rights, increasing share capital and the capital surplus by ¥780,000 each. - FY2023-Q3MaterialisedAnnual report
「1 January 2023– 31 March 2023 2,000 3,275,000 240 301,484 240 293,986 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the third quarter accounting period, the exercise of stock acquisition rights resulted in an increase of 2,000 shares and increased share capital and the capital surplus by ¥240,000 each. - FY2023-Q2MaterialisedAnnual report
「1 October 2022–31 December 2022 500 3,273,000 60 301,244 60 293,746 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the second quarter accounting period, the exercise of stock acquisition rights resulted in an increase of 500 shares, increasing the total number of shares issued, share capital and the capital surplus. - FY2022MaterialisedAnnual report
「Increase resulting from the exercise of stock acquisition rights: 9,000 shares」
During the consolidated fiscal year, 9,000 shares were issued through the exercise of stock acquisition rights, and dilution from stock options continued to be reflected in actual results. - FY2022-Q2MaterialisedAnnual report
「1 October 2021–31 December 2021 7,000 3,271,500 840 301,064 840 293,566 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the second quarter, 7,000 shares were issued through the exercise of stock acquisition rights, increasing share capital and the capital surplus by ¥840,000 each. - FY2022-Q1MaterialisedAnnual report
「1 July 2021–30 September 2021 1,000 3,264,500 120 300,224 120 292,726 (Note) Increase resulting from the exercise of stock acquisition rights.」
The exercise of stock acquisition rights resulted in an increase of 1,000 shares and increased share capital and the capital surplus by ¥120,000 each. Dilution from stock options and other instruments continues to be reflected in actual results. - FY2021-Q3MaterialisedAnnual report
「1 January 2021– 31 March 2021 1,500 3,263,500 180 300,104 180 292,606 (Note) Increase resulting from the exercise of stock acquisition rights.」
The exercise of stock acquisition rights resulted in an increase of 1,500 shares and increased share capital and the capital surplus by ¥180,000 each. - FY2021-Q1MaterialisedAnnual report
「1 July 2020–30 September 2020 4,000 3,262,000 480 299,924 480 292,426 (Note) Increase resulting from the exercise of stock acquisition rights.」
The exercise of stock acquisition rights resulted in an increase of 4,000 shares and increased share capital and the capital surplus by ¥480,000 each. - FY2020MaterialisedAnnual report
「Increase resulting from the exercise of stock acquisition rights: 72,000 shares」
During the consolidated fiscal year, 72,000 shares were issued through the exercise of stock acquisition rights, and 122,000 unexercised rights remained at the end of the fiscal year. - FY2020-Q2MaterialisedAnnual report
「1 October 2019–31 December 2019 (Note) 4,000 3,258,000 480 299,444 480 291,946 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the second quarter, 4,000 shares were issued through the exercise of stock acquisition rights, increasing share capital and the capital surplus by ¥480,000 each. - FY2020-Q1MaterialisedAnnual report
「1 July 2019–30 September 2019 68,000 3,254,000 8,160 298,964 8,160 291,466 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the first quarter, 68,000 shares were issued through the exercise of stock acquisition rights, increasing share capital and the capital surplus by ¥8.160 million each. - FY2019-Q3MaterialisedAnnual report
「Exercise of 30 Series 3 Stock Acquisition Rights」
The company states that 30 Series 3 Stock Acquisition Rights were exercised, resulting in an increase of 175,512 common shares used to calculate diluted quarterly net income per share, and diluted quarterly net income per share of ¥34.01. - FY2018First statedAnnual report
「During the consolidated fiscal year, the potential shares represented by these stock options totaled 196,500 shares, equivalent to 7.38% of the 2,661,500 shares issued before the public offering.」
The company discloses the number of potential shares under its incentive plan for officers and employees and their percentage of shares issued before the public offering, noting the potential dilution of existing shareholders' equity value.